• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Elligo Health Research names Deirdre BeVard COO

Elligo Health Research names Deirdre BeVard COO

August 30, 2017
CenterWatch Staff

Elligo Health Research, a clinical research infrastructure provider that brings together sponsors, physicians, patients and CROs to improve clinical trial access and efficiency, has hired Deirdre BeVard as chief operating officer.

BeVard’s innovative approaches to investigative site training, online site communities and adaptive study management will support Elligo’s Goes Direct approach by removing barriers to patient participation and retention and simplifying participation in research studies. In addition, she will help physicians improve processes and conduct studies in their own clinics.

Over the past 25 years, BeVard has held leadership roles in clinical affairs and development operations. Most recently, she was vice president of development of Nektar Therapeutics. Responsible for clinical trial leadership, data management and outsourcing, she increased the company’s capacity to efficiently execute early- and late-stage trials.

BeVard is a member of the editorial board of Clinical Leader and is also the recipient of the HBA Rising Star Award from the Healthcare Businesswomen’s Association. A frequent conference speaker, BeVard will present Sept. 7 at DPharm in the Innovative Sources and Solutions track, with a presentation titled “Once Lost, Now Found: Discovering the last-mile solution to accessing patients in healthcare.”

“BeVard’s experience and passion for creating clinical trial efficiencies perfectly align with our core mission,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “Through her analysis and fostering of productive stakeholder relationships, she will create environments that enhance the clinical trial process for sponsors, physicians and patients.”

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing